Abstract: The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including CF Transmembrane Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Abstract: A work bench having elevated support members. The work bench may comprise a generally rectangular frame defined by two elongated members and two side members; a support base for supporting the generally rectangular frame in a generally horizontal plane; a plurality of cross members disposed in between the two side members, each of the plurality of cross members being generally parallel to the two side members and being coupled to the two elongated members; and a plurality of raised blocks located on top of each of the two side members and each of the plurality of cross members, wherein the plurality of raised blocks located on each of the two side members are distributed substantially evenly along each of the two side members, and the plurality of raised blocks located on each of the plurality of cross members are distributed substantially evenly along each of the plurality of cross members.

Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Abstract: The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Abstract: The present invention provides compounds of Formula I useful as modulators of ABC transporter activity, or a pharmaceutically acceptable salt thereof, wherein RB, n, B, RC, RD, RE, A, and Z are described generally and in classes and subclasses below. The present invention also provides pharmaceutical compositions, methods and kits associated with Formula I, useful for as modulators, and for the treatments of disease and disease conditions associated with ABC transporter proteins.

Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Abstract: The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

Abstract: The present invention relates to compounds useful as promoters of the SMN2 gene. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of Spinal Muscular Atrophy.

Abstract: The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

Abstract: A short message transaction system has a computer that communicates in an online Internet protocol that forms active sessions. A wireless device communicates in a protocol that transmits and receives messages that have a maximum size limit of a predetermined number of alphanumeric characters substantially smaller than the number of alphanumeric characters transmitted in a communication of the computer. A database is also provided. A surrogate communicates with the wireless device and the computer. The surrogate collects data from a plurality of messages from the wireless device and provides the data for storage in the database. The computer then runs online sessions using the stored data.

Abstract: A short message transaction system has a computer that communicates in an online Internet protocol that forms active sessions. A wireless device communicates in a protocol that transmits and receives messages that have a maximum size limit of a predetermined number of alphanumeric characters substantially smaller than the number of alphanumeric characters transmitted in a communication of the computer. A database is also provided. A surrogate communicates with the wireless device and the computer. The surrogate collects data from a plurality of messages from the wireless device and provides the data for storage in the database. The computer then runs online sessions using the stored data.

Abstract: Photoluminescent complexes of copper, silver, zinc, lithium or similar metals are described, being (bis)ligand, with two different ligands. A variety of ligands may be used, the larger ligand being of a size or shape such that a pair of such ligand are prevented by steric properties from forming a (bis)ligand complex with the metal. Preferred substituents may be alkyl, aryl or alkaryl hydrocarbons, or halogen, chalcogen, nitrogen or phosphorus moieties, or included heteroatoms. Formation of the (bis)ligand complex is accomplished by maintaining the molar ratios of reactants at that which is equivalent to the (bis)ligand complex composition. The complexes are useful as optical sensors for O2, NH3 and NOx, in dye sensitization for photovoltaic devices/solar cells, in producing visible TiO2 photosensitization and in H2 production from the photochemically splitting water. These heteroleptic complexes exhibit photoluminescence equal to or better than ruthenium homoleptic complexes.

Abstract: A drape for surgical procedures on a shoulder. The drape includes a flexible sheet of fluid impervious material intended to overlay a patient arranged in either a lateral position or a beach chair position. The sheet includes a shoulder accommodating fenestration, and the resilient construction of the sheet around the fenestration causes the sheet to generally conform to a patient's shoulder area after the patient's arm is inserted through the fenestration. A pair of fluid collection pouches are connected to the sheet in a fluid tight fashion on opposite sides of the fenestration, and are arranged such that fluids present at the shoulder during the surgical procedure flow by gravity into one or both of the fluid collection pouches. A method of draping a patient for shoulder surgery is also disclosed.